Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
Advancing K-Ras Targeted Therapies with Innovative Detection Methods
The RAS family of genes, particularly K-Ras, plays a critical role in cancer biology. Despite its notorious difficulty as a therapeutic target, recent breakthroughs have brought new hope in treating cancers driven by K-Ras mutations.
Our latest application note delves into innovative approaches to K-Ras inhibition, including small molecule inhibitors, synthetic lethality strategies, and PROTAC® molecules. We also showcase the high specificity and sensitivity of the no-wash HTRF™ K-Ras immunoassay, a cutting-edge tool that offers a reliable and precise method for evaluating K-Ras protein levels, outperforming traditional techniques. Discover how this assay can accelerate your research in targeting the elusive K-Ras.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Advancing K-Ras Targeted Therapies with Innovative Detection Methods